AgenT is a diagnostics company developing the first blood test to diagnose Alzheimer’s disease before symptoms develop. Current diagnostics tools available (PET scan and lumbar puncture) are invasive with low sensitivity and specificity for screening Alzheimer’s during the pre-dementia stages when it can be prevented. AgenT’s blood test combines Machine Learning and multi-omics biomarkers to rapidly and accurately diagnose pre-dementia Alzheimer’s.